5 COVID Vaccine Stocks With Late-Stage Candidates You'll Want to Watch

·3 min read

More COVID-19 vaccines could be on the way. While hundreds of millions of people around the world have received shots from the vaccines that are already approved or authorized, several other vaccine candidates are currently in late-stage testing. In this Motley Fool Live video, recorded on Sept. 8, Fool contributors Keith Speights and Brian Orelli discuss five stocks to watch that could be winners if those late-stage clinical trials are successful.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting